Senores Pharmaceuticals Limited (BOM:544319)
India · Delayed Price · Currency is INR 1,042.95
-5.85 (-0.56%)
At close: Jun 4, 2026
Senores Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,164 | 585.6 | 314.5 | 84.33 | 9.91 |
Depreciation & Amortization | 312.5 | 168.1 | 94.6 | 3.69 | 1.42 |
Other Amortization | - | 0.3 | 5.6 | 14.1 | 5.63 |
Loss (Gain) From Sale of Assets | -1 | - | - | - | - |
Other Operating Activities | 563.7 | 131.1 | -11.2 | 33.19 | 3.89 |
Change in Accounts Receivable | -1,973 | -118.8 | -571.1 | -24.74 | -194 |
Change in Inventory | -303.4 | -192.6 | -10.4 | -1.42 | -26.44 |
Change in Accounts Payable | 1,605 | -457.9 | 509 | 64.46 | 70.07 |
Change in Other Net Operating Assets | -747 | -575 | -588 | -184.4 | 25.05 |
Operating Cash Flow | 620.5 | -459.2 | -257 | -10.79 | -104.47 |
Capital Expenditures | -2,647 | -1,575 | -518.3 | -472.77 | -106.82 |
Sale of Property, Plant & Equipment | 1.8 | - | - | - | - |
Cash Acquisitions | -318.5 | -36.9 | -32.9 | - | - |
Investment in Securities | 1,619 | -2,758 | - | -10.49 | -139.52 |
Other Investing Activities | 139.9 | 71.6 | 4.7 | 0.39 | 1.94 |
Investing Cash Flow | -1,206 | -4,295 | -542.3 | -482.87 | -244.4 |
Short-Term Debt Issued | - | 922 | 580.4 | 290.4 | 15.06 |
Long-Term Debt Issued | 176.8 | 295.4 | 31.7 | 175.46 | 89.93 |
Total Debt Issued | 176.8 | 1,217 | 612.1 | 465.86 | 104.99 |
Short-Term Debt Repaid | -156.8 | - | - | - | - |
Long-Term Debt Repaid | - | - | -13.7 | - | -0.87 |
Total Debt Repaid | -156.8 | - | -13.7 | - | -0.87 |
Net Debt Issued (Repaid) | 20 | 1,217 | 598.4 | 465.86 | 104.12 |
Issuance of Common Stock | 236.2 | 4,718 | 369.9 | 26.82 | 240.21 |
Other Financing Activities | -269.5 | -203.7 | -98.5 | -30.17 | 20.29 |
Financing Cash Flow | -13.3 | 5,731 | 869.8 | 462.51 | 364.62 |
Miscellaneous Cash Flow Adjustments | 0.1 | - | 5 | - | - |
Net Cash Flow | -598.3 | 977.3 | 75.5 | -31.15 | 15.75 |
Free Cash Flow | -2,027 | -2,034 | -775.3 | -483.56 | -211.29 |
Free Cash Flow Margin | -32.04% | -51.08% | -36.14% | -136.84% | -149.11% |
Free Cash Flow Per Share | -45.96 | -55.94 | -30.09 | -38.12 | -38.53 |
Cash Interest Paid | 250.3 | 203.6 | 85 | 18.37 | 5.1 |
Cash Income Tax Paid | 132 | 91.7 | 24.9 | 14.53 | 1.41 |
Levered Free Cash Flow | -2,859 | -2,414 | -1,035 | -543.86 | - |
Unlevered Free Cash Flow | -2,703 | -2,287 | -982 | -532.38 | - |
Change in Working Capital | -1,419 | -1,344 | -660.5 | -146.1 | -125.32 |